132 related articles for article (PubMed ID: 38563363)
1. Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype-Phenotype Correlations.
Schmidt VF; Kapp FG; Goldann C; Huthmann L; Cucuruz B; Brill R; Vielsmeier V; Seebauer CT; Michel AJ; Seidensticker M; Uller W; Weiß JBW; Sint A; Häberle B; Haehl J; Wagner A; Cordes J; Holm A; Schanze D; Ricke J; Kimm MA; Wohlgemuth WA; Zenker M; Wildgruber M;
J Am Heart Assoc; 2024 Apr; 13(8):e033287. PubMed ID: 38563363
[TBL] [Abstract][Full Text] [Related]
2. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations.
El Sissy FN; Wassef M; Faucon B; Salvan D; Nadaud S; Coulet F; Adle-Biassette H; Soubrier F; Bisdorff A; Eyries M
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):905-912. PubMed ID: 35238086
[TBL] [Abstract][Full Text] [Related]
4. Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
Li M; Richter S; Mohr H; Drukewitz S; Poser I; Stanke D; Calsina B; Martinez-Montes AM; Quinkler M; Timmers HJLM; Nölting S; Beuschlein F; Remde H; Opocher G; Rapizzi E; Pacak K; Pamporaki C; Robledo M; Liu L; Jiang J; Bornstein SR; Eisenhofer G; Fliedner SMJ; Bechmann N
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902037
[TBL] [Abstract][Full Text] [Related]
5. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 Han Chinese patients with cervical carcinoma.
Zou Y; Liu FY; Wu J; Wan L; Fang SF; Zhang ZY; Luo Y; Chen MH; Huang MZ; He M; Huang OP
Oncol Lett; 2017 Aug; 14(2):2427-2431. PubMed ID: 28781678
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of RAS variants in patients with disorders of somatic mosaicism.
Claire Hou YC; Evenson MJ; Corliss MM; Mahapatra L; Aldawood A; Carpentieri DF; Chamlin SL; Kulungowski AM; Madan-Khetarpal S; Sebastian J; Pet MA; Coughlin CC; Willing MC; Pearson GD; Setty BA; El-Haffaf Z; Cottrell CE; Parikh BA; Krysiak K; Schroeder MC; Heusel JW; Neidich JA; Cao Y
Genet Med; 2023 Mar; 25(3):100348. PubMed ID: 36571464
[TBL] [Abstract][Full Text] [Related]
9. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
[TBL] [Abstract][Full Text] [Related]
10. Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay.
Su J; Zhang XC; An SJ; Zhong WZ; Huang Y; Chen SL; Yan HH; Chen ZH; Guo WB; Huang XS; Wu YL
Chin J Cancer; 2014 Jul; 33(7):346-50. PubMed ID: 24823994
[TBL] [Abstract][Full Text] [Related]
11. Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.
Gao S; Nelson J; Weinsheimer S; Winkler EA; Rutledge C; Abla AA; Gupta N; Shieh JT; Cooke DL; Hetts SW; Tihan T; Hess CP; Ko N; Walcott BP; McCulloch CE; Lawton MT; Su H; Pawlikowska L; Kim H
J Neurosurg; 2022 Jan; 136(1):148-155. PubMed ID: 34214981
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Villaruz LC; Socinski MA; Abberbock S; Berry LD; Johnson BE; Kwiatkowski DJ; Iafrate AJ; Varella-Garcia M; Franklin WA; Camidge DR; Sequist LV; Haura EB; Ladanyi M; Kurland BF; Kugler K; Minna JD; Bunn PA; Kris MG
Cancer; 2015 Feb; 121(3):448-56. PubMed ID: 25273224
[TBL] [Abstract][Full Text] [Related]
13. Concomitant RAS and BRAF mutation in colorectal cancer - A report of 7 cases.
Ates O; Yalcin S
Indian J Cancer; 2019; 56(2):176-179. PubMed ID: 31062740
[TBL] [Abstract][Full Text] [Related]
14. Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.
Yokota T; Shibata N; Ura T; Takahari D; Shitara K; Muro K; Yatabe Y
Transl Res; 2010 Aug; 156(2):98-105. PubMed ID: 20627194
[TBL] [Abstract][Full Text] [Related]
15. Mosaic RASopathies: A review of disorders caused by somatic pathogenic variants in the genes of the RAS/MAPK pathway.
Carli D; Resta N; Ferrero GB; Ruggieri M; Mussa A
Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):520-529. PubMed ID: 36461154
[TBL] [Abstract][Full Text] [Related]
16. Histiocytic neoplasms in the era of personalized genomic medicine.
Durham BH; Diamond EL; Abdel-Wahab O
Curr Opin Hematol; 2016 Jul; 23(4):416-25. PubMed ID: 27101528
[TBL] [Abstract][Full Text] [Related]
17. Coincidence of v-raf murine sarcoma viral oncogene homolog B mutation (V595E) with phosphorylated v-raf murine sarcoma viral oncogene homolog B in urothelial carcinoma in dogs.
Yamasaki H; Uematsu Y; Hayashi Y; Yamashita M; Tei M; Uchida K; Ono K; Hirao H
Can J Vet Res; 2022 Oct; 86(4):286-293. PubMed ID: 36211215
[TBL] [Abstract][Full Text] [Related]
18. Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies.
Mussa A; Turchiano A; Cardaropoli S; Coppo P; Pantaleo A; Bagnulo R; Ranieri C; Iacoviello M; Garganese A; Stella A; Vallero SG; Bertin D; Santoro F; Carli D; Ferrero GB; Resta N
Genes Chromosomes Cancer; 2022 Nov; 61(11):689-695. PubMed ID: 35778969
[TBL] [Abstract][Full Text] [Related]
19. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
[TBL] [Abstract][Full Text] [Related]
20. Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.
Jackson M; Ahmari N; Wu J; Rizvi TA; Fugate E; Kim MO; Dombi E; Arnhof H; Boehmelt G; Düchs MJ; Long CJ; Maier U; Trapani F; Hofmann MH; Ratner N
J Pharmacol Exp Ther; 2023 May; 385(2):106-116. PubMed ID: 36849412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
